The production value of biotechnology research and experimental development in Sweden stood at 285 million Euros in 2023. Analyzing year-on-year variations, there is a noticeable steady growth in production value with a marked increase in 2018 (25.65%) and 2019 (18.84%), followed by more moderate growth rates in subsequent years. The last two years show year-on-year variations of 4.68% (2022) and 4.43% (2023). The Compound Annual Growth Rate (CAGR) over the last five years is 7.62%, indicating robust overall growth in the sector.
Future trends to watch for include the forecasted production value reaching 344.8 million Euros by 2028, with a forecasted 5-year CAGR of 3.02%. This suggests continued but slower growth compared to previous years. Innovations, policy changes, and international collaboration will be critical in shaping the biotechnology landscape in Sweden.
